We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+33%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$19.5B
AUM Growth
+$4.67B
Cap. Flow
+$750M
Cap. Flow %
3.84%
Top 10 Hldgs %
35.61%
Holding
917
New
102
Increased
528
Reduced
232
Closed
53

Sector Composition

Rank Sector Weight
1 Materials 57.74%
2 Energy 17%
3 Healthcare 5.04%
4 Industrials 2.41%
5 Technology 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFCFA
151
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$16.5M 0.08%
+609,448
New +$17.8M
NVDA icon
152
NVIDIA
NVDA
$5.06T
$16.5M 0.08%
14,015,800
+5,908,120
+73% +$6.09M
AXP icon
153
American Express
AXP
$233B
$16.5M 0.08%
+270,786
New +$17.2M
AMAT icon
154
Applied Materials
AMAT
$447B
$16M 0.08%
667,763
+235,683
+55% +$5.2M
STT icon
155
State Street
STT
$50.6B
$15.7M 0.08%
291,549
-292,592
-50% -$17.5M
SLCA
156
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$15.7M 0.08%
455,671
+58,268
+15% +$1.61M
CBRE icon
157
CBRE Group
CBRE
$39.7B
$15.3M 0.08%
578,029
-665,069
-54% -$19.5M
NLY icon
158
Annaly Capital Management
NLY
$16.7B
$15.3M 0.08%
344,997
+23,862
+7% +$1.02M
ADI icon
159
Analog Devices
ADI
$185B
$15.3M 0.08%
269,278
+144,703
+116% +$8.29M
RDC
160
DELISTED
Rowan Companies Plc
RDC
$14.8M 0.08%
836,575
-234,401
-22% -$4.06M
ARCC icon
161
Ares Capital
ARCC
$13.4B
$14.5M 0.07%
1,020,612
+106,333
+12% +$1.58M
RIO icon
162
Rio Tinto
RIO
$149B
$14.3M 0.07%
456,537
+159,837
+54% +$4.77M
OIS icon
163
Oil States International
OIS
$522M
$14.2M 0.07%
433,219
-20,902
-5% -$677K
JLL icon
164
Jones Lang LaSalle
JLL
$14.8B
$14.2M 0.07%
146,147
-149,188
-51% -$17.1M
MU icon
165
Micron Technology
MU
$1.12T
$14.2M 0.07%
1,034,790
+468,058
+83% +$5.32M
NXPI icon
166
NXP Semiconductors
NXPI
$70B
$14M 0.07%
178,776
+70,826
+66% +$6.07M
VEON icon
167
VEON
VEON
$3.6B
$13.9M 0.07%
143,543
-36,403
-20% -$3.42M
QGENF
168
DELISTED
QIAGEN NV
QGENF
$13.5M 0.07%
620,735
-136,813
-18% -$2.98M
GSK icon
169
GSK
GSK
$102B
$13.5M 0.07%
248,523
-10,755
-4% -$567K
NVS icon
170
Novartis
NVS
$297B
$13.4M 0.07%
181,078
-18,597
-9% -$1.28M
NE
171
DELISTED
Noble Corporation
NE
$13.4M 0.07%
1,623,840
+280,659
+21% +$2.68M
SNY icon
172
Sanofi
SNY
$104B
$13.3M 0.07%
318,983
-3,020
-0.9% -$124K
ABBV icon
173
AbbVie
ABBV
$454B
$13.3M 0.07%
214,494
-15,827
-7% -$964K
BMY icon
174
Bristol-Myers Squibb
BMY
$126B
$13.2M 0.07%
179,894
-17,808
-9% -$1.26M
GRFS
175
Grifois
GRFS
$5.13B
$13.2M 0.07%
793,173
-96,564
-11% -$1.52M

Similar funds

VanEck Associates's Q2 2016 Portfolio in Review

As of Q2 2016, VanEck Associates held 917 positions worth $19.5B, up 31% from $14.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

VanEck Associates deployed $750M of net new capital in Q2 2016, opening 102 new positions and adding to 528 existing holdings. Its largest new stake was Innovex International: 334,392 shares worth $19.5M.

By sector, the portfolio is most concentrated in Materials at 58% of assets, up from 48% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Valero Energy, an estimated $134M trimmed.

  • VanEck Associates's largest Q2 2016 buy was Innovex International: 334,392 shares worth $19.5M.
  • VanEck Associates added most to Newmont in Q2 2016, an estimated $271M increase.
  • VanEck Associates's biggest Q2 2016 reduction was Valero Energy, cutting an estimated $134M.
  • VanEck Associates fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $45.1M.
  • VanEck Associates's ten largest holdings make up 36% of its $19.5B portfolio in Q2 2016.
  • VanEck Associates opened 102 new positions and closed 53 in Q2 2016.
  • VanEck Associates's portfolio value rose 31% quarter-over-quarter to $19.5B.

Based on VanEck Associates's 13F filing for Q2 2016, filed 12 Aug 2016.